FI368374A - - Google Patents

Info

Publication number
FI368374A
FI368374A FI3683/74A FI368374A FI368374A FI 368374 A FI368374 A FI 368374A FI 3683/74 A FI3683/74 A FI 3683/74A FI 368374 A FI368374 A FI 368374A FI 368374 A FI368374 A FI 368374A
Authority
FI
Finland
Application number
FI3683/74A
Other languages
Finnish (fi)
Inventor
C A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI368374A publication Critical patent/FI368374A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
FI3683/74A 1973-12-26 1974-12-19 FI368374A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42844173A 1973-12-26 1973-12-26

Publications (1)

Publication Number Publication Date
FI368374A true FI368374A (fr) 1975-06-27

Family

ID=23698907

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3683/74A FI368374A (fr) 1973-12-26 1974-12-19

Country Status (21)

Country Link
JP (1) JPS582937B2 (fr)
AR (1) AR205807A1 (fr)
BE (1) BE823811A (fr)
CA (1) CA1035360A (fr)
DD (1) DD117454A5 (fr)
DE (1) DE2461050C2 (fr)
DK (1) DK138889B (fr)
ES (1) ES433305A1 (fr)
FI (1) FI368374A (fr)
FR (1) FR2255906B1 (fr)
GB (1) GB1454039A (fr)
HU (1) HU169380B (fr)
IE (1) IE40329B1 (fr)
IL (1) IL46232A0 (fr)
LU (1) LU71558A1 (fr)
NL (1) NL7416666A (fr)
NO (1) NO744670L (fr)
RO (1) RO64270A (fr)
SE (1) SE421417B (fr)
SU (1) SU538663A3 (fr)
ZA (1) ZA748171B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978064A (en) * 1975-11-04 1976-08-31 Pfizer Inc. 3-Aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters and intermediates leading thereto

Also Published As

Publication number Publication date
FR2255906B1 (fr) 1978-06-30
DD117454A5 (fr) 1976-01-12
ZA748171B (en) 1976-01-28
DK138889C (fr) 1979-04-30
HU169380B (fr) 1976-11-28
DK653874A (fr) 1975-08-25
CA1035360A (fr) 1978-07-25
DE2461050C2 (de) 1983-12-29
SU538663A3 (ru) 1976-12-05
AR205807A1 (es) 1976-06-07
JPS582937B2 (ja) 1983-01-19
RO64270A (fr) 1979-05-15
NL7416666A (nl) 1975-06-30
GB1454039A (en) 1976-10-27
DE2461050A1 (de) 1975-07-17
IE40329B1 (en) 1979-05-09
JPS50105672A (fr) 1975-08-20
BE823811A (fr) 1975-06-24
SE7415497L (fr) 1975-06-27
LU71558A1 (fr) 1975-08-20
AU7658174A (en) 1976-06-24
IE40329L (en) 1975-06-26
ES433305A1 (es) 1977-03-01
SE421417B (sv) 1981-12-21
IL46232A0 (en) 1975-03-13
FR2255906A1 (fr) 1975-07-25
DK138889B (da) 1978-11-13
NO744670L (fr) 1975-07-21

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU477823B2 (fr)
AU461342B2 (fr)
AR197627A1 (fr)
AR200885A1 (fr)
AR200256A1 (fr)
AU477824B2 (fr)
AR210729A1 (fr)
AR201432A1 (fr)